Choi WJ, Perez FM, Gravely A, Ivanics T, Claasen MPAW, Abraham L, Abreu P, Visser R, Gallinger S, Hansen BE, Sapisochin G
Backgrounds/Aims: Within two years of surgery, 70% of resected intrahepatic cholangiocarcinoma (iCCA) recur. Better biomarkers are needed to identify those at risk of “early recurrence” (ER). In this study, we...